Showing results (1-10 of 154) with videos related to
Sort By:
Pageof 16
Expert Opinion on Biological Therapy|August 29, 2003
Glycoconjugate vaccines to prevent group B streptococcal infectionsLawrence C Paoletti, Dennis L KasperMicrobiology Spectrum|March 16, 2019
Surface Structures of Group B Streptococcus Important in Human ImmunityLawrence C Paoletti, Dennis L KasperThe Journal of Infectious Diseases|June 29, 2002
Conjugate vaccines against group B Streptococcus types IV and VIILawrence C Paoletti, Dennis L KasperProceedings of the National Academy of Sciences of the United States of America|April 2, 2008
Rational chemical design of the carbohydrate in a glycoconjugate vaccine enhances IgM-to-IgG switchingHilde-Kari Guttormsen, Lawrence C Paoletti, Keith G Mansfield, et al.The Journal of Infectious Diseases|June 26, 2003
Safety and immunogenicity of a bivalent group B streptococcal conjugate vaccine for serotypes II and IIICarol J Baker, Marcia A Rench, Marisol Fernandez, et al.The Journal of Infectious Diseases|March 5, 2004
Immune response of healthy women to 2 different group B streptococcal type V capsular polysaccharide-protein conjugate vaccinesCarol J Baker, Lawrence C Paoletti, Marcia A Rench, et al.Infection and Immunity|March 16, 2002
Type III group B streptococcal polysaccharide induces antibodies that cross-react with Streptococcus pneumoniae type 14Hilde-Kari Guttormsen, Carol J Baker, Moon H Nahm, et al.Nestle Nutrition Workshop Series. Paediatric Programme|August 28, 2009
A paradigm for commensalism: the role of a specific microbial polysaccharide in health and diseaseDennis L KasperThe Journal of Infectious Diseases|November 26, 2002
Neutralizing antibody induced in mice by novel glycoconjugates of human immunodeficiency virus type 1 gp120 and env2-3Lawrence C Paoletti, Ronald C KennedySeminars in Neonatology : SN|October 29, 2002
Vaccines to prevent neonatal GBS infectionLawrence C Paoletti, Lawrence C MadoffPageof 16